Quang X. Pham, Chairman, CEO and Interim CFO: Cadrenal Therapeutics CVKD Planned sale · Filed 06/15

Trade details

Type: Planned sale notice
Stock: Cadrenal Therapeutics CVKD
Person: Quang X. PhamChairman, CEO and Interim CFO
Planned sale date: 26/06/15
Filed: 26/06/15

More to sell after $266.5K in 3 months

Cadrenal Therapeutics trades, last 26 weeks

What else happened in Cadrenal Therapeutics around then

Filed or reported within 30 days of the trade day · 05/16~07/15

Quang X. Pham's recent trades

Quang X. PhamChairman, CEO and Interim CFO
Sell10b5-1 planCadrenal Therapeutics
Sell10b5-1 plan
Cadrenal Therapeutics
CVKD
$27.5K
9,029 sh
$27.5K
Filed 06/26
Traded 06/26
Quang X. PhamChairman, CEO and Interim CFO
Sell10b5-1 planCadrenal Therapeutics
Sell10b5-1 plan
Cadrenal Therapeutics
CVKD
$6,381
2,127 sh
$6,381
Filed 06/26
Traded 06/25
Quang X. PhamChairman, CEO and Interim CFO
Sell10b5-1 planCadrenal Therapeutics
Sell10b5-1 plan
Cadrenal Therapeutics
CVKD
$32.5K
9,167 sh
$32.5K
Filed 06/24
Traded 06/22
Quang X. PhamChairman, CEO and Interim CFO
Sell10b5-1 planCadrenal Therapeutics
Sell10b5-1 plan
Cadrenal Therapeutics
CVKD
$7,286
2,277 sh
$7,286
Filed 06/24
Traded 06/23
Quang X. PhamChairman, CEO and Interim CFO
Sell10b5-1 planCadrenal Therapeutics
Sell10b5-1 plan
Cadrenal Therapeutics
CVKD
$11.5K
3,613 sh
$11.5K
Filed 06/18
Traded 06/16